Back

Long term outcomes of patent foramen ovale closure in elderly patients

29 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Patent foramen ovale and atrial septal defect closure: indications, techniques, and long-term outcomes Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Andrea Tripoli

IRCCS San Raffaele Scientific Institute, Milan (Italy)

4 More presentations in this session

Presentation thumbnail
Effectiveness of intraprocedural guidance modalities on PFO closure outcomes: insights from the PROLONG registry
Doctor P. Costa (Brescia, IT)
Abstract Slides Video
Presentation thumbnail
Shunt-related platelet activation in patients with patent foramen ovale
Doctor B. Goessinger (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Pre-procedural shunt characteristics and residual shunting at 6 months after percutaneous PFO closure
Mr J. Nieuwendijk (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Tailoring antiplatelet therapy duration after PFO closure: insights from the PROLONG registry
Doctor A. Tripoli (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Patent foramen ovale and atrial septal defect closure: indications, techniques, and long-term outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Long term follow-up of patent foramen closure due to embolic infarction in elderly patients
26 August 2023
thumbnail
Congress Presentation
Embolic events after left atrial appendage closure for recurrent embolic events despite anticoagulation
29 August 2026
thumbnail
Congress Presentation
Prevalence, determinants, and impact of significant shunt after percutaneous patent foramen ovale closure
2 September 2024
thumbnail
Congress Presentation
Pulmonary vascular hemodynamics in patients undergoing percutaneous closure of a patent foramen ovale
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources